Clearside Biomedical (FRA:CLM) Beginning Cash Position : €13.26 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Clearside Biomedical Beginning Cash Position?

Clearside Biomedical's Beginning Cash Position for the quarter that ended in Dec. 2024 was €13.26 Mil.

Clearside Biomedical's quarterly Beginning Cash Position declined from Jun. 2024 (€32.85 Mil) to Sep. 2024 (€16.43 Mil) and declined from Sep. 2024 (€16.43 Mil) to Dec. 2024 (€13.26 Mil).

Clearside Biomedical's annual Beginning Cash Position increased from Dec. 2022 (€28.98 Mil) to Dec. 2023 (€44.40 Mil) but then declined from Dec. 2023 (€44.40 Mil) to Dec. 2024 (€27.62 Mil).

Clearside Biomedical Beginning Cash Position Historical Data

The historical data trend for Clearside Biomedical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearside Biomedical Beginning Cash Position Chart

Clearside Biomedical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

18.87

15.62

28.98

44.40

27.62

Clearside Biomedical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															26.41	26.61	32.85	16.43	13.26

Clearside Biomedical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Clearside Biomedical Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Clearside Biomedical's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearside Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearside Biomedical Inc (FRA:CLM) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CLSD:USA CLM:Germany

Address

900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005

Website

https://www.clearsidebio.com

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.